These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 7940960

  • 1. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T, Stepkowski SM, Smith S, Kahan BD.
    Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract] [Full Text] [Related]

  • 2. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM, Kahan BD.
    Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM, Tu Y, Chou TC, Kahan BD.
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dose-dependent effect of intrathymically injected 3-mol/L KCl-extracted histocompatibility antigens to prolong heart allograft survival in rats.
    Hamashima T, Stepkowski SM, Kahan BD.
    Transplant Proc; 1995 Feb; 27(1):134-5. PubMed ID: 7878904
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y, Waer M.
    Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
    [No Abstract] [Full Text] [Related]

  • 8. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
    Stepkowski SM, Wang M, Qu X, Yu J, Okamoto M, Tejpal N, Kahan BD.
    Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
    [No Abstract] [Full Text] [Related]

  • 9. Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats.
    Stepkowski SM, Chen H, Daloze P, Kahan BD.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):507-8. PubMed ID: 1990602
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection.
    Ferraresso M, Wang ME, Stepkowski SM, Kahan BD.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):729. PubMed ID: 8438460
    [No Abstract] [Full Text] [Related]

  • 12. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM, Kahan BD.
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract] [Full Text] [Related]

  • 13. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
    Hamashima T, Yoshimura N, Ohsaka Y, Oka T, Stepkowski SM, Kahan BD.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prolongation of cardiac allograft survival in rats following combination treatment with 2-chloro-2'-deoxyadenosine and cyclosporine: a novel immunosuppressive strategy.
    Nawrocki G, Grieb P, Górski A, Danielewicz R, Rowiński W.
    Transplant Proc; 1996 Dec; 28(6):3538-9. PubMed ID: 8962374
    [No Abstract] [Full Text] [Related]

  • 16. Induction of transplantation tolerance by a single intrathymic injection of 3M KCl-extracted donor histocompatibility antigens combined with two doses of anti-rat alpha/beta-T cell receptor monoclonal antibodies.
    Hamashima T, Stepkowski SM, Smith S, Kahan BD.
    Transplantation; 1994 Jul 15; 58(1):105-7. PubMed ID: 8036696
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
    Marquet RL, de Bruin RW, Heineman E, Jeekel J.
    Transplant Proc; 1993 Aug 15; 25(4):2695-6. PubMed ID: 8356718
    [No Abstract] [Full Text] [Related]

  • 18. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
    Goggins WC, Fisher RA, Cohen DS, Tawes JW, Grimes MM.
    J Heart Lung Transplant; 1996 Aug 15; 15(8):790-5. PubMed ID: 8878761
    [Abstract] [Full Text] [Related]

  • 19. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K.
    Transplant Proc; 1996 Apr 15; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract] [Full Text] [Related]

  • 20. LF 08-0299 induces tolerance after short-term treatment in a fully major histocompatibility mismatched rat cardiac allograft model.
    Dutartre P, Annat J, Derrepas P.
    Transplant Proc; 1995 Feb 15; 27(1):440-2. PubMed ID: 7879054
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.